pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: The Turkish Version of the Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Status: COMPLETED
Conditions: Premature|Infant Development|Environmental Exposure
Interventions: OTHER: The Affordances in the Home Environment for Motor Development-Infant Scale (AHEMD-IS)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/Lymphoma
Status: UNKNOWN
Conditions: T-cell Leukemia/Lymphoma|Refractory T Lymphoblastic Leukemia/Lymphoma|Relapse/Recurrence
Interventions: BIOLOGICAL: chimeric antigen receptor T cell treatment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: DWC20155|DRUG: DWC20156
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
Status: COMPLETED
Conditions: Shock
Interventions: DRUG: Hydrocortisone|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Development of Health Monitoring System on Patient's Well Being in Dialysis Context
Status: NOT_YET_RECRUITING
Conditions: Quality of Life|Self Efficacy|Chronic Kidney Diseases|M-health
Interventions: BEHAVIORAL: Using m-health for monitoring and education provision|OTHER: Standard care
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Electrocautery vs Q-switch for Seborrheic Keratosis
Status: WITHDRAWN
Conditions: Keratosis, Seborrheic
Interventions: DEVICE: Hyfrecator|DEVICE: 532 nm Q-switched Nd:YAG laser
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine
Status: ACTIVE_NOT_RECRUITING
Conditions: Glioblastoma Multiforme|Recurrent Glioblastoma
Interventions: COMBINATION_PRODUCT: TTFields and SRS
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and Mastectomy
Status: NOT_YET_RECRUITING
Conditions: Breast Cancer
Interventions: RADIATION: Arm I (No PMRT)|RADIATION: Arm II (PMRT)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority Patients
Status: COMPLETED
Conditions: Major Depressive Disorder
Interventions: BEHAVIORAL: Mindfulness Based Stress Reduction and Psychoeducation|BEHAVIORAL: Psychoeducation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Semiconductor Heat Extraction Cooling
Status: COMPLETED
Conditions: Hyperthermia
Interventions: OTHER: Hand Cooling at 12-15 degrees celsius|OTHER: Hand Cooling at 16-20 degrees celsius|OTHER: hand and back cooling at 12-15 or 16-20 degrees celsius|OTHER: Passive cooling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
Status: TERMINATED
Conditions: HIV Infection
Interventions: DRUG: tenofovir + abacavir + lopinavir/ritonavir|DRUG: tenofovir + abacavir + efavirenz
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: WCK 4873|DRUG: Placebo Oral Tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Effect of Haptic Cueing on Long-Range Autocorrelations in Parkinson's Disease Gait Variability
Status: COMPLETED
Conditions: Parkinson Disease|Gait, Unsteady
Interventions: OTHER: No cueing versus Haptic cueing versus Auditory cueing during parkinson's disease gait
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
Status: COMPLETED
Conditions: Preoperative Skin Preparation
Interventions: DRUG: Octenidine Dihydrocloride in aqueous solution|OTHER: Vehicle Control|OTHER: Saline Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
Status: COMPLETED
Conditions: Crohn Disease
Interventions: DRUG: Risankizumab 600 mg IV|DRUG: Risankizumab 180 mg SC
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Transection of Sternothyroid Muscle Increases the Rate of Exposure of the External Laryngeal Nerve During Thyroidectomy
Status: COMPLETED
Conditions: Thyroid|Surgery|Thyroid Disease
Interventions: PROCEDURE: thyroidectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
Status: NOT_YET_RECRUITING
Conditions: Advanced Solid Tumors
Interventions: DRUG: Duvelisib|DRUG: SG001
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.
Status: UNKNOWN
Conditions: Intracranial Pressure Increase
Interventions: DEVICE: Medical Device Vittamed 205
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Multimodal and Unimodal Analgesia in Cholecystectomy
Status: COMPLETED
Conditions: Compare Unimodal and Multimodal Analgesics
Interventions: DRUG: Pregabalin 150mg|DRUG: Acetaminophen 1 G Oral Tablet|DRUG: Celecoxib 400Mg Oral Capsule
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus
Status: ACTIVE_NOT_RECRUITING
Conditions: Diabetes Mellitus, Type 2|Coronary Artery Disease
Interventions: DRUG: Ticagrelor monotherapy|DRUG: Ticagrelor plus aspirin|DRUG: Clopidogrel with aspirin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Electrical Stimulation and Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer
Status: COMPLETED
Conditions: Diabetic Foot
Interventions: PROCEDURE: Electrical Stimulation|PROCEDURE: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia
Status: COMPLETED
Conditions: Vascular Disease|Critical Lower Limb Ischemia
Interventions: DRUG: Hemospan (MP4OX)|DRUG: Voluven (HES 130/0.4)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Lorcaserin in Obesity: Identification of CNS Targets Using fMRI
Status: ACTIVE_NOT_RECRUITING
Conditions: Obesity|Weight Loss
Interventions: DRUG: Lorcaserin HCl|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Enhancing Mother-Child Ties and Psychosocial Wellness Through Arts Among Children With Intellectual Disability and Their Mothers
Status: RECRUITING
Conditions: Intellectual Disability|Mother-Child Relations
Interventions: BEHAVIORAL: The Dyadic Expressive Arts Group Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Status: ACTIVE_NOT_RECRUITING
Conditions: Parkinson's Disease
Interventions: DRUG: BIA 28-6156 10 mg|DRUG: BIA 28-6156 60 mg|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Pivotal Study of the Aptus Endovascular AAA Repair System
Status: COMPLETED
Conditions: Abdominal Aortic Aneurysms (AAA)
Interventions: DEVICE: Aptus Endovascular AAA Repair System
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
Status: COMPLETED
Conditions: Kidney Transplantation|Kidney Disease
Interventions: DRUG: Alemtuzumab|DRUG: Sirolimus|DRUG: Tacrolimus|PROCEDURE: Kidney transplant|DRUG: Methylprednisolone (or equivalent)|DRUG: Acetaminophen|DRUG: Diphenhydramine|DRUG: Trimethoprim (TMP)/Sulfa (Bactrim, Septra)|DRUG: Valgancyclovir|DRUG: Acyclovir|DRUG: Pentamidine|DRUG: Clotrimazole|DRUG: Nystatin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Investigating the Incretin Effect in Cystic Fibrosis
Status: COMPLETED
Conditions: Cystic Fibrosis
Interventions: DRUG: Oral Glucose Tolerance test (75g 2-hour)|DRUG: Modified Oral Glucose Tolerance Test (50g 4-hours)|DRUG: Matched isoglycemic clamp|DRUG: Hyperglycemic clamp with concurrent GLP-1 infusion|DRUG: Hyperglycemic Clamp with concurrent GIP infusion|DRUG: Hyperglycemic clamp with placebo infusion|OTHER: Liquid Meal Test (Carbohydrate-rich)|OTHER: Liquid Meal Test (Fat-rich)|OTHER: Liquid Meal Test (Mixed)|DEVICE: Continuous Glucose Monitoring
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Hospitalised Pneumonia With Extended Treatment (HOPE) Study
Status: UNKNOWN
Conditions: Pneumonia
Interventions: DRUG: Amoxicillin-clavulanic Acid|DRUG: Placebo (for Amoxicillin-clavulanic Acid)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Pragmatic Impact of Proteomic Risk Stratification in Diabetes Mellitus
Status: COMPLETED
Conditions: Type 2 Diabetes
Interventions: OTHER: SomaSignal Cardiovascular Risk in Type 2 Diabetes (CVD-T2D) Test and SomaSignal Metabolic Factors test
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy
Status: COMPLETED
Conditions: Focal Onset Seizures
Interventions: DRUG: JNJ-40411813|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Status: TERMINATED
Conditions: Diabetes Mellitus Type 1|Autoimmune Diabetes
Interventions: DRUG: Insulin|DRUG: Lansoprazole|DRUG: Sitagliptin|BIOLOGICAL: Diamyd|DRUG: GAD65 (Diamyd)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Physiotherapist-supervised Rehabilitation After Proximal Humerus Fracture
Status: COMPLETED
Conditions: Proximal Humeral Fracture
Interventions: OTHER: Physiotherapist-supervised training|OTHER: Home-based training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
Status: COMPLETED
Conditions: Advanced Solid Tumor|Cholangiocarcinoma|HER2-negative Breast Cancer|Triple Negative Breast Cancer|Bladder Cancer|Small-cell Lung Cancer|Prostate Cancer|Thyroid Cancer|Sarcoma|Gastric Cancer|Gallbladder Cancer
Interventions: DRUG: TT-00420|COMBINATION_PRODUCT: Nab-Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
Status: ACTIVE_NOT_RECRUITING
Conditions: Limb-Girdle Muscular Dystrophy, Type 2E
Interventions: GENETIC: SRP-9003
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer
Status: COMPLETED
Conditions: Lymphedema|Breast Cancer
Interventions: PROCEDURE: Self-measured arm circumference, therapist-measured arm-circumference, perometer-measured arm circumference
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients
Status: UNKNOWN
Conditions: Hepatitis B, Chronic
Interventions: DRUG: Recombinant anti-programmed death-1 (PD-1) humanized monoclonal antibody|DRUG: Nucleoside/nucleotide analogues
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
Status: COMPLETED
Conditions: Neoplasms
Interventions: DRUG: Bevacizumab|DRUG: BAY 43-9006
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: McGrath Videolaryngoscopy for Nasotracheal Intubation
Status: COMPLETED
Conditions: Nasotracheal Intubation
Interventions: DEVICE: McGrath videolaryngoscopy|DEVICE: Macintosh laryngoscopy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury
Status: COMPLETED
Conditions: Pain
Interventions: DRUG: Fentanyl|DRUG: Fentanyl|DRUG: Oxycodone/acetaminophen|DRUG: oxycodone/acetaminophen
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery
Status: TERMINATED
Conditions: Acute Kidney Injury
Interventions: DRUG: BCT197 Part A|DRUG: Placebo|DRUG: BCT197 Part B
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
Status: UNKNOWN
Conditions: Rotavirus Infections
Interventions: BIOLOGICAL: ROTAVAC®
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
Status: UNKNOWN
Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy
Interventions: DRUG: Intra-vitreal injection of bevacizumab (1.25mg/0.05ml)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Status: UNKNOWN
Conditions: Chronic Hepatitis B
Interventions: DRUG: Pegasys plus Entecavir|DRUG: Entecavir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
Status: COMPLETED
Conditions: Pulmonary Arterial Hypertension
Interventions: DRUG: bosentan|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Budesonide/Formoterol fumarate dihydrate|DRUG: Symbicort|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Temporomandibular Joint and Soft Tissue Mobilisation Techniques on Bening Paroxymal Vertigo
Status: COMPLETED
Conditions: Soft Tissue Mobilisation|Vestibular Exercises|Physiotherapy|Vertigo, Paroxysmal|Temporomandibular Joint Disorders
Interventions: BEHAVIORAL: Study Group|OTHER: Control Group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)
Status: COMPLETED
Conditions: Depression
Interventions: DRUG: Citalopram + Pipamperone|DRUG: Citalopram
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
Status: TERMINATED
Conditions: 2019 Novel Coronavirus Infection|COVID-19 Virus Infection|SARS Coronavirus 2 Infection|SARS-CoV-2 Infection|Respiratory Distress Syndrome, Adult|Adult Respiratory Distress Syndrome
Interventions: DRUG: USB002|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy, Safety and Pharmacokinetics of DTG With RIF
Status: RECRUITING
Conditions: HIV/TB Coinfection
Interventions: DRUG: DTG 50 mg OD with food|DRUG: DTG 50 mg BID
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome
Status: COMPLETED
Conditions: COVID-19|Mechanical Ventilation|Quality of Life|Radiologic Increased Density of Lung|Sedation|Complication of Treatment
Interventions: OTHER: Invasive mechanical ventilation
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Status: RECRUITING
Conditions: Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma
Interventions: DRUG: [18F]PT2385|PROCEDURE: Positron Emission Tomography/Computed Tomography|PROCEDURE: Biopsy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in At-risk Older Adults (The Exergames Telerehabilitation Study)
Status: RECRUITING
Conditions: At Risk for AD-dementia, With Subjective Cognitive Decline
Interventions: BEHAVIORAL: HbAEx|BEHAVIORAL: HbExergame
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
Status: COMPLETED
Conditions: Diabetes|Healthy
Interventions: DRUG: liraglutide|DRUG: placebo|DRUG: liraglutide|DRUG: liraglutide|DRUG: insulin human|DRUG: insulin human|DRUG: liraglutide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Massage for Newborns Receiving Nasal CPAP
Status: NOT_YET_RECRUITING
Conditions: Massage|Stress|Newborn|Comfort
Interventions: OTHER: Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Use of TXA to Prevent Postpartum Hemorrhage
Status: UNKNOWN
Conditions: Post Partum Hemorrhage
Interventions: DRUG: TXA (1g)|DRUG: Placebo (0.9% saline)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Partial Versus Total Fundoplication in the Surgical Repair of Para-esophageal Hernia.
Status: COMPLETED
Conditions: Paraesophageal Hernia|Gastro Esophageal Reflux
Interventions: PROCEDURE: Addition of 360 fundoplication after crural closure|PROCEDURE: Addition of 180 posterior fundoplication after crural closure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: COMPLETED
Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: DRUG: high dose clonidine HCl sustained release|DRUG: low dose clonidine HCl sustained release|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Psychosexual Caring Program on Sexual Well-being of Infertile Women
Status: COMPLETED
Conditions: Sexuality|Nursing Caries|Infertility, Female
Interventions: OTHER: Psychosexual care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Gastric In Vivo Study
Status: TERMINATED
Conditions: Gastric Cancer
Interventions: DRUG: Proflavine Hemisulphate salt|PROCEDURE: White-light examination|PROCEDURE: Imaging with High Resolution Microendoscope
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Clinical Investigation of the TECNIS® Next-Generation Intraocular Lens, Model DEN00V
Status: TERMINATED
Conditions: Cataracts
Interventions: DEVICE: investigational IOL Model DEN00V|DEVICE: control IOL Model ZCB00/DCB00
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Malnutrition Screening by Muscle Ultrasound in Patients Requiring Mechanical Ventilation in Intensive Care Unit
Status: TERMINATED
Conditions: Malnutrition|Critical Illness
Interventions: OTHER: Measure of quadriceps thickness with ultrasonography and albumin/prealbumin levels
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Effect of Palpatory Neuromodulation of the Trigeminal Nerve for Tenderness in the Posterior Neck Musculature
Status: COMPLETED
Conditions: Neuromodulation|Neck Pain
Interventions: OTHER: neuromodulation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Heat Transport Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults
Status: UNKNOWN
Conditions: Chronic Stable Angina Pectoris
Interventions: DIAGNOSTIC_TEST: Infrared thermal imaging|PROCEDURE: Moxibustion
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Status: NOT_YET_RECRUITING
Conditions: Coronary Heart Disease
Interventions: DRUG: Single anti-platelet therapy|DRUG: Dual anti-platelet therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia
Status: COMPLETED
Conditions: Pain
Interventions: DRUG: Gabapentin|DRUG: Diphenhydramine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy
Status: UNKNOWN
Conditions: Kidney Neoplasms|Renal Cell Carcinoma
Interventions: PROCEDURE: Segmental artery clamping|PROCEDURE: Main renal artery clamping
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.
Status: NOT_YET_RECRUITING
Conditions: Dyspnea
Interventions: DRUG: Nitric Oxide|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Enoxaparin prefilled syringes|DRUG: Dabigatran etexilate capsules
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma
Status: WITHDRAWN
Conditions: Recurrent Follicular Lymphoma|Refractory Follicular Lymphoma
Interventions: DRUG: Tazemetostat|BIOLOGICAL: Ublituximab|DRUG: Umbralisib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease
Status: RECRUITING
Conditions: Squamous Cell Carcinoma
Interventions: OTHER: Standard surveillance|OTHER: Telemedicine surveillance (tele-surveillance)|OTHER: Questionnaires
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Incidence and Effects of Sleep Apnea on Intracerebral Aneurysms
Status: UNKNOWN
Conditions: Sleep Apnea (Defined as Apnea Hypopnea Index > 5/h)|Intracranial Aneurysm Size|Blood Pressure Medication|Comorbidities|Complications (Subarachnoid Hemorrhage)
Interventions: DEVICE: Cardiorepiratory Polygraphy
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Extrauterine Placental Transfusion In Neonatal Resuscitation Of Very Low Birth Weight Infants
Status: COMPLETED
Conditions: Very Low Birth Weight Infant|Placental Transfusion|Anemia
Interventions: PROCEDURE: Extrauterine placental transfusion (Intervention group)|PROCEDURE: Delayed cord clamping (Control group)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Prediction of Intraoperative Blood Loss and Postoperative Recovery by Liver Stiffness Measurement (Fibroscan®) in Right Hepatectomy
Status: COMPLETED
Conditions: Liver Malignancy
Interventions: OTHER: preoperative liver stiffness measurement
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Study of Different Forms of Danicopan (Tablet, Softgel Capsule, Liquid-filled Capsule) in Healthy Participants
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Danicopan - Tablet|DRUG: Danicopan - Softgel|DRUG: Danicopan - LFC
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Twice Yearly Treatment for the Control of LF
Status: COMPLETED
Conditions: Lymphatic Filariasis|Helminth Infection
Interventions: DRUG: 400 μg/kg Ivermectin + 400 mg Albendazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Tight Glycaemic Control During Cardiac Surgery
Status: TERMINATED
Conditions: Nosocomial Infection|External Causes of Morbidity and Mortality|Hypoglycemia
Interventions: DRUG: TGC|DRUG: Conventional glycaemic control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab
Status: TERMINATED
Conditions: Cancer
Interventions: DRUG: Leucovorin|DRUG: Fluorouracil - bolus|DRUG: Bevacizumab|DRUG: Fluorouracil - infusion|DRUG: ABT-165|DRUG: Irinotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients
Status: WITHDRAWN
Conditions: Prostatic Neoplasms, Castration-Resistant
Interventions: DRUG: Abiraterone|DRUG: Apalutamide
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Cold Physical Treatment to Manage Insulin Resistance
Status: COMPLETED
Conditions: Insulin Resistance|Hyperglycemia|Hyperinsulinemia|Diabetes|Obesity
Interventions: PROCEDURE: Selective Cold|DEVICE: Electroacupuncture
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
Status: COMPLETED
Conditions: Nocturia
Interventions: DRUG: Desmopressin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen
Status: COMPLETED
Conditions: Central Retinal Vein Occlusion
Interventions: DRUG: Aflibercept|DRUG: Ranibizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications
Status: UNKNOWN
Conditions: Intestinal Complications|Laparotomy
Interventions: PROCEDURE: Ischemic preconditioning|DRUG: Dexmedetomidine|PROCEDURE: Patient-controlled epidural analgesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Hypnotic Intake and Motor and Cognitive Performances at High Altitude
Status: COMPLETED
Conditions: Physiology
Interventions: DRUG: Zolpidem|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
Status: TERMINATED
Conditions: Prevention of Hangover Using N-Acety Cysteine
Interventions: DIETARY_SUPPLEMENT: N-acetyl cysteine|OTHER: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
Status: TERMINATED
Conditions: Bipolar|Depression
Interventions: DRUG: Lisdexamfetamine|DRUG: Placebo control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study Between the Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients
Status: UNKNOWN
Conditions: Adverse Anesthesia Outcome
Interventions: DEVICE: Laryngeal Tube Suction Disposable|DEVICE: Laryngeal Mask Airway AuraGain
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy Participants
Status: COMPLETED
Conditions: Neoplasm, Advanced or Metastatic
Interventions: DRUG: TAK-117|DRUG: Lansoprazole|DRUG: TAK-117
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate
Status: COMPLETED
Conditions: Rheumatoid Arthritis
Interventions: DRUG: VX-509|DRUG: VX-509 matching placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101
Status: WITHDRAWN
Conditions: Ovarian Cancer|Cervical Cancer|Colorectal Cancer|Stomach Cancer
Interventions: BIOLOGICAL: LYN00101
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Safety, Tolerability, and Pharmacokinetic Study of GDC-3280 in Healthy Participants
Status: COMPLETED
Conditions: Healthy Volunteer
Interventions: DRUG: GDC-3280|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers
Status: TERMINATED
Conditions: COVID-19|Protection Against COVID-19 and Infections With SARS-CoV- 2|COVID-19 Immunisation
Interventions: BIOLOGICAL: COVID-eVax|DEVICE: Cliniporator® and EPSGun
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease
Status: COMPLETED
Conditions: SARS-CoV-2|Systemic Lupus Erythematosus|Rheumatoid Arthritis|Sjogren's Syndrome|Psoriatic Arthritis
Interventions: OTHER: Questionnaire by phone call
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Addition of Naltrexone to Methadone Taper
Status: COMPLETED
Conditions: Heroin Dependence|Opioid-Related Disorders|Substance-Related Disorders
Interventions: DRUG: Naltrexone|DRUG: Placebo comparator|DRUG: naltrexone|DRUG: naltrexone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Personalized Nutrition Advice for Optimizing Dietary Habits and Metabolic Status
Status: COMPLETED
Conditions: Personalized Nutrition|Health Status|Dietary Habits
Interventions: OTHER: Personalized nutrition group|OTHER: Personalized Plan group|OTHER: Control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Efficacy of Cognitive Restructuring and Imagery Modification to Reduce the Feeling of Being Contaminated After Childhood Sexual Abuse
Status: COMPLETED
Conditions: Sexual Abuse|Posttraumatic Stress Disorder
Interventions: BEHAVIORAL: Imagery Modification|BEHAVIORAL: Waitlist control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of a Neuromuscular Exercise Program and Visual Feedback in the Management of Body Position for Stroke Survivors
Status: UNKNOWN
Conditions: Brain Ischemia|Stroke, Ischemic
Interventions: OTHER: Standard physiotherapy|DEVICE: Biodex Balance SD and Biodex Gait Trainer
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: terbutaline sulphate delivered dose|DRUG: terbutaline sulphate metered dose
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Status: TERMINATED
Conditions: Eosinophilic Gastroenteritis|Eosinophilic Esophagitis
Interventions: DRUG: sirolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Single Dose Preoperative Gabapentin Use in Minimally Invasive Hysterectomy for Acute Pain Management
Status: COMPLETED
Conditions: Pain, Postoperative
Interventions: DRUG: Gabapentin|DRUG: Acetaminophen|DRUG: Celecoxib
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
Status: COMPLETED
Conditions: Cataract
Interventions: DRUG: Levofloxacin + Dexamethasone|DRUG: Levofloxacin|DRUG: Dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
Status: COMPLETED
Conditions: Bipolar Disorder|Attention Deficit Hyperactivity Disorder
Interventions: DRUG: Aripiprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: A Bioequivalence Study to Compare the Pharmacokinetics (PK) Of Marketed Product TobraDex® To An Experimental Ophthalmic Sterile Ointment Containing Tobramycin And Dexamethasone In Aqueous Humor In Patients Undergoing Indicated Cataract Surgery
Status: COMPLETED
Conditions: Bilateral Cataract
Interventions: DRUG: cataract surgery
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose:
Clinical trial: Ultrasound-guided Erector Spinae Plane Block Versus Paravertebral Block in Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction - a Non-inferiority Trial
Status: RECRUITING
Conditions: Breast Cancer Patients Undergoing Mastectomy With Immediate Reconstruction
Interventions: DRUG: Morphine|OTHER: Ultrasound-guided erector spinae plane block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients
Status: COMPLETED
Conditions: COVID-19
Interventions: DRUG: Povidone-Iodine|DRUG: Essential oils|OTHER: Tap water
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir
Status: COMPLETED
Conditions: Infection, Human Immunodeficiency Virus
Interventions: DRUG: GSK1349572 (Cohort I)|DRUG: GSK1349572 (Cohort II)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease
Status: COMPLETED
Conditions: Crohn Disease|Insomnia|Sleep Disturbance|Pain|Inflammation
Interventions: BEHAVIORAL: Cognitive Behavioral Therapy for Insomnia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Acyline|DRUG: Acyline + Testosterone gel|DRUG: Acyline + testosterone gel + anastrozole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Clinical trial: Screening and Brief Intervention Via IVR for Problematic Use of Alcohol: A Randomized Controlled Trial
Status: COMPLETED
Conditions: Problem Drinking
Interventions: BEHAVIORAL: Short IVR|BEHAVIORAL: Therapeutic IVR
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Forearm vs Brachial Plexus Blockade for Routine Hand and Wrist Surgery
Status: UNKNOWN
Conditions: Post-operative Pain Management
Interventions: DRUG: Forearm Nerve Block|DRUG: Brachial Plexus Block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Clinical Trial in Females for Female Pattern Hair Loss
Status: COMPLETED
Conditions: Androgenetic Alopecia
Interventions: DRUG: 5% Minoxidil Topical Foam|DRUG: Vehicle Topical Foam
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Scopolamine Treatment for Patients With Organophosphate Poisoning
Status: WITHDRAWN
Conditions: Neurotoxicity Syndromes
Interventions: DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Periodontal Dressing After Surgical Crown Lengthening
Status: COMPLETED
Conditions: Pain|Wound Healing Disturbance of|Periodontal Infection
Interventions: PROCEDURE: With Periodontal dressing|PROCEDURE: Without Periodontal dressing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
Status: UNKNOWN
Conditions: Glaucoma
Interventions: DRUG: Xalost S|DRUG: Xalatan|DRUG: Taflotan-S
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Tablet-based Interactive Distraction Preoperative Anxiety in Children: A Randomized Controlled Trial
Status: UNKNOWN
Conditions: Children Under General Anaesthesia
Interventions: DEVICE: TIBD|DRUG: Midazolam
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Kangaroo Mother Care to Prevent Hypothermia in Term Infants
Status: COMPLETED
Conditions: Hypothermia|Newborn
Interventions: OTHER: Continuous Kangaroo Mother Care to one hour after birth|OTHER: Standard Kangaroo Mother Care to one hour after birth|OTHER: Continuous Kangaroo Mother Care to discharge|OTHER: Standard Kangaroo Mother Care to discharge
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Status: COMPLETED
Conditions: Type I Hypersensitivity
Interventions: BIOLOGICAL: Grass MATAMPL
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Status: RECRUITING
Conditions: Hepatocellular Carcinoma, Childhood|Fibrolamellar Carcinoma|Liver Cancer|Liver Cancer, Pediatric
Interventions: DRUG: Pembrolizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT